Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes
Seongwon Hwang, Ville Karhunen, Ashish Patel…·Stephen Burgess
This study uses genetic data to show that HMGCR inhibition affects coronary artery disease and type 2 diabetes through different causal pathways, with BMI and LDL-C playing distinct roles.